Literature DB >> 8857118

Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia.

C Camus1, C Charasse, I Jouannic-Montier, P Seguin, Y L Tulzo, J Bouget, R Thomas.   

Abstract

OBJECTIVE: To assess the efficacy, adverse effects and relevance of calcium-free hemodialysis (CFHD) in the treatment of major hypercalcemia.
DESIGN: Retrospective chart review.
SETTING: Medical ICU. PATIENTS: All patients admitted over a 9-year period for hypercalcemia requiring urgent treatment and who underwent hemodialysis.
INTERVENTIONS: CFHD with an acetate dialysate. MAIN
RESULTS: Thirty-three patients with severe hypercalcemia from various etiologies received CFHD. Marked and rapid decrease of serum total calcium was obtained during all sessions (mean decrease: 1.71 +/- 0.54 mmol/l). Calcium rebound within 24 h after CFHD was observed in all evaluable cases (1 +/- 0.45 mmol/l; mean delay 13.7 +/- 5.8 h). Adverse cardiovascular effects occurred in 17 of 48 sessions (35%) and in 13 of 30 evaluable patients (43%).
CONCLUSIONS: Adverse effects are frequent during CFHD. After correction of hypovolemia, its use should be restricted to patients with severe clinical symptoms or advanced renal impairment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857118     DOI: 10.1007/bf01720717

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  37 in total

Review 1.  Metabolic coma.

Authors:  C R Kleeman
Journal:  Kidney Int       Date:  1989-12       Impact factor: 10.612

2.  Role of dialysis in the treatment of severe hypercalcemia: report of two cases successfully treated with hemodialysis and review of the literature.

Authors:  C J Cardella; B L Birkin; A Rapoport
Journal:  Clin Nephrol       Date:  1979-12       Impact factor: 0.975

3.  Acute primary hyperparathyroidism: experience of 59 cases.

Authors:  E Sarfati; L Desportes; D Gossot; C Dubost
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

4.  Pernicious hyperparathyroidism.

Authors:  H Johansson; L Thorén; I Werner
Journal:  Acta Chir Scand       Date:  1973

5.  Normocalcemic hyperparathyroidism culminating in hypercalcemic crisis. Treatment with hemodialysis.

Authors:  E Eisenberg; F A Gotch
Journal:  Arch Intern Med       Date:  1968-09

6.  Renal failure associated with intravenous diphosphonates.

Authors:  H M Bounameaux; J Schifferli; J P Montani; A Jung; F Chatelanat
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

7.  Relative hypercalcemia in acute renal failure.

Authors:  S M Gibson; P L Kimmel
Journal:  Am J Kidney Dis       Date:  1989-11       Impact factor: 8.860

Review 8.  Treatment of hypercalcemia.

Authors:  M F Attie
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

9.  Calcium free hemodialysis: an effective therapy in hypercalcemic crisis--report of 4 cases.

Authors:  W Kaiser; G Biesenbach; R Kramar; J Zazgornik
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

10.  Lethal hyperparathyroid crisis: hazards of phosphate administration.

Authors:  A M Vernava; L W O'Neal; V Palermo
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

View more
  9 in total

1.  Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia.

Authors:  V Srámek; I Novák; M Matĕjovic; R Rokyta; M Nalos; P Hora; H Pittrová
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

2.  Calcium-free hemodialysis for hypercalcemia of malignancy in a newborn.

Authors:  Madhura Pradhan; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2003-04-05       Impact factor: 3.714

3.  [Hypercalcemic crisis].

Authors:  J Pfeilschifter
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

4.  Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.

Authors:  Yan Yu; Ming Bai; Zhang Wei; Lijuan Zhao; Yangping Li; Feng Ma; Shiren Sun
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

5.  Severe hypercalcemia requiring acute hemodialysis: A retrospective cohort study with increased incidence during the Covid-19 pandemic.

Authors:  Y Bentata; M Benabdelhak; I Haddiya; N Oulali; B Housni
Journal:  Am J Emerg Med       Date:  2021-11-12       Impact factor: 4.093

6.  The use of hemodialysis in refractory hypercalcemia secondary to parathyroid carcinoma.

Authors:  Huai Heng Loh; Nurain Mohd Noor
Journal:  Case Rep Crit Care       Date:  2014-01-21

7.  Severe hypercalcemia as a form of acute lymphoblastic leukemia presentation in children.

Authors:  Andreia Luís Martins; Marta Moniz; Pedro Sampaio Nunes; Clara Abadesso; Helena Cristina Loureiro; Ximo Duarte; Helena Isabel Almeida
Journal:  Rev Bras Ter Intensiva       Date:  2015 Oct-Dec

Review 8.  HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview.

Authors:  Abdullah Ebrahim Laher; Osman Ebrahim
Journal:  Pan Afr Med J       Date:  2018-05-28

9.  Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report.

Authors:  Buyun Wu; Jing Wang; Guang Yang; Changying Xing; Huijuan Mao
Journal:  BMC Nephrol       Date:  2018-06-14       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.